R Tanosaki Selected Research

R Tanosaki Research Topics

Disease

6	Neoplasms (Cancer) 01/2017 - 02/2001
6	Infections 04/2016 - 02/2001
4	Graft vs Host Disease (Graft-Versus-Host Disease) 08/2004 - 05/2001
3	Adult T-Cell Leukemia-Lymphoma (Leukemia Lymphoma, T Cell, Acute, HTLV I Associated) 01/2016 - 11/2002
3	Myelodysplastic Syndromes (Myelodysplastic Syndrome) 03/2005 - 10/2002
2	Hematologic Neoplasms (Hematological Malignancy) 04/2016 - 10/2001
2	Neutropenia 01/2013 - 02/2001
2	Pneumonia (Pneumonitis) 01/2013 - 07/2001
2	Hemorrhagic Cystitis 07/2008 - 12/2003
2	Bacteremia 07/2008 - 03/2005
2	Aspergillosis 07/2008 - 10/2002
2	Bronchiolitis Obliterans 06/2005 - 11/2004
2	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 03/2005 - 05/2004
2	Abscess 01/2003 - 01/2001
1	Hemorrhage 01/2013
1	Fever (Fevers) 01/2013
1	Bronchiolitis Obliterans Syndrome 07/2008
1	Bacterial Pneumonia 07/2008
1	Colitis 03/2008
1	Enterocolitis 06/2006
1	Guillain-Barre Syndrome 03/2006
1	Non-Hodgkin Lymphoma (Lymphosarcoma) 03/2005
1	Residual Neoplasm 03/2005
1	Sepsis (Septicemia) 03/2005
1	Refractory Anemia with Excess of Blasts (RAEM) 03/2005
1	Refractory Anemia 03/2005
1	Bradycardia 01/2005
1	Disease Progression 05/2004
1	Psoriasis (Pustulosis Palmaris et Plantaris) 08/2003
1	Lymphoma (Lymphomas) 07/2003
1	Meningoencephalitis 01/2003
1	Lymphoid Leukemia 11/2002
1	Peripheral T-Cell Lymphoma (Lymphoma, T Cell, Peripheral) 11/2002
1	Precursor T-Cell Lymphoblastic Leukemia-Lymphoma (T-ALL) 11/2002
1	Ulcer 10/2002
1	Pneumocystis Pneumonia (Pneumocystis carinii Pneumonia) 07/2001
1	Paroxysmal Hemoglobinuria (Paroxysmal Nocturnal Hemoglobinuria) 05/2001
1	T-Cell Leukemia (Leukemia, T Cell) 03/2001
1	Leukemia 01/2001
1	Cardiotoxicity 01/2000
1	Breast Neoplasms (Breast Cancer) 01/2000

Drug/Important Bio-Agent (IBA)

5	Cyclosporine (Ciclosporin)FDA LinkGeneric 01/2005 - 05/2001
2	SteroidsIBA 04/2016 - 11/2004
2	Anti-Bacterial Agents (Antibiotics)IBA 01/2013 - 10/2002
2	Ganciclovir (Cytovene)FDA LinkGeneric 02/2002 - 02/2001
1	mogamulizumabIBA 01/2016
1	C-Reactive ProteinIBA 01/2013
1	HLA Antigens (Human Leukocyte Antigens)IBA 07/2008
1	Prednisolone (Predate)FDA LinkGeneric 07/2008
1	Peptides (Polypeptides)IBA 03/2008
1	Immunosuppressive Agents (Immunosuppressants)IBA 05/2005
1	Immunoglobulin Heavy Chains (Immunoglobulin Heavy Chain)IBA 03/2005
1	Adrenal Cortex Hormones (Corticosteroids)IBA 03/2005
1	Tacrolimus (Prograf)FDA LinkGeneric 08/2004
1	Methotrexate (Mexate)FDA LinkGeneric 08/2003
1	Vancomycin FDA LinkGeneric 01/2003
1	T-Cell Antigen Receptors (T-Cell Receptor)IBA 11/2002
1	gamma-delta T-Cell Antigen Receptors (T-Cell Receptor delta-Chain)IBA 11/2002
1	alpha-beta T-Cell Antigen Receptors (T-Cell Receptor alpha-Chain)IBA 11/2002
1	Cladribine FDA LinkGeneric 10/2002
1	Busulfan (Busulfex)FDA Link 10/2002
1	thymoglobulin FDA Link 10/2002
1	Sulfamethoxazole Drug Combination Trimethoprim (Co-Trimoxazole)FDA LinkGeneric 07/2001
1	DNA (Deoxyribonucleic Acid)IBA 03/2001
1	AnthracyclinesIBA 01/2000

Therapy/Procedure

16	Hematopoietic Stem Cell Transplantation 01/2017 - 02/2001
7	Stem Cell Transplantation 06/2006 - 01/2000
6	Transplantation 03/2005 - 05/2001
5	Drug Therapy (Chemotherapy) 05/2005 - 01/2000
3	Therapeutics 01/2013 - 10/2002
2	Peripheral Blood Stem Cell Transplantation (Peripheral Stem Cell Transplantation) 01/2003 - 07/2001
1	Central Venous Catheters 07/2008
1	Induction Chemotherapy 03/2005
1	Homologous Transplantation 01/2001